Literature DB >> 14500378

A molecular fingerprint for medulloblastoma.

Youngsoo Lee1, Heather L Miller, Patricia Jensen, Roberto Hernan, Michele Connelly, Cynthia Wetmore, Frederique Zindy, Martine F Roussel, Tom Curran, Richard J Gilbertson, Peter J McKinnon.   

Abstract

Medulloblastoma is the most common malignant pediatric brain tumor. In mice, Ptc1 haploinsufficiency and disruption of DNA repair (DNA ligase IV inactivation) or cell cycle regulation (Kip1, Ink4d, or Ink4c inactivation), in conjunction with p53 dysfunction, predispose to medulloblastoma. To identify genes important for this tumor, we evaluated gene expression profiles in medulloblastomas from these mice. Unexpectedly, medulloblastoma expression profiles were very similar among tumors and also to those of developing cerebellum. However, 21 genes were specifically up-regulated in medulloblastoma, including sFrp1, Ptc2, and Math1, members of signaling pathways that regulate cerebellar development. Coordinated deregulation of these same genes also occurred in a large subset of human medulloblastomas. These data identify a group of genes that is central to medulloblastoma tumorigenesis.

Entities:  

Mesh:

Year:  2003        PMID: 14500378

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  78 in total

1.  Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation.

Authors:  Jennifer Pogoriler; Kathleen Millen; Manuel Utset; Wei Du
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

Review 2.  Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Authors:  Iacopo Sardi; Duccio Cavalieri; Maura Massimino
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

3.  Hedgehog signaling promotes medulloblastoma survival via Bc/II.

Authors:  Eli E Bar; Aneeka Chaudhry; Mohamed H Farah; Charles G Eberhart
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  BMPs oppose Math1 in cerebellar development and in medulloblastoma.

Authors:  Matthew R Grimmer; William A Weiss
Journal:  Genes Dev       Date:  2008-03-15       Impact factor: 11.361

5.  Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity.

Authors:  Nicole C Johnson; Miriam E Dillard; Peter Baluk; Donald M McDonald; Natasha L Harvey; Sharon L Frase; Guillermo Oliver
Journal:  Genes Dev       Date:  2008-12-01       Impact factor: 11.361

6.  N-myc alters the fate of preneoplastic cells in a mouse model of medulloblastoma.

Authors:  Jessica D Kessler; Hiroshi Hasegawa; Sonja N Brun; Brian A Emmenegger; Zeng-Jie Yang; John W Dutton; Fan Wang; Robert J Wechsler-Reya
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

7.  Conditional MN1-TEL knock-in mice develop acute myeloid leukemia in conjunction with overexpression of HOXA9.

Authors:  Hiroyuki Kawagoe; Gerard C Grosveld
Journal:  Blood       Date:  2005-08-16       Impact factor: 22.113

8.  BRCA2 is required for neurogenesis and suppression of medulloblastoma.

Authors:  Pierre-Olivier Frappart; Youngsoo Lee; Jayne Lamont; Peter J McKinnon
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

9.  Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers.

Authors:  Alvin T Kho; Qing Zhao; Zhaohui Cai; Atul J Butte; John Y H Kim; Scott L Pomeroy; David H Rowitch; Isaac S Kohane
Journal:  Genes Dev       Date:  2004-03-15       Impact factor: 11.361

10.  REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma.

Authors:  Lucia Di Marcotullio; Elisabetta Ferretti; Enrico De Smaele; Beatrice Argenti; Claudia Mincione; Francesca Zazzeroni; Rita Gallo; Laura Masuelli; Maddalena Napolitano; Marella Maroder; Andrea Modesti; Felice Giangaspero; Isabella Screpanti; Edoardo Alesse; Alberto Gulino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.